US Market Open: US indices to hold steady
Joshua Warner December 22, 2020 12:01 PM
US markets are expected to open broadly flat following a sell-off yesterday driven by fears over a new strain of the coronavirus.
- US markets are expected to open broadly flat, following European indices that are largely holding steady at midday following the heavy sell-off yesterday.
- The approval of a new US stimulus package has provided some confidence to markets but concerns over a new strain of the coronavirus is proving a headwind.
- In commodity markets, Brent was holding steady above $50 as concerns over a new strain of the virus prevents oil prices moving higher.
US indices hold steady
The S&P 500 is called to open 0.1% higher at 3698.4 after ending yesterday at 3693.6.
The Dow Jones is set to open broadly flat at 30196.0 from 30199.0 at the end of play on Monday.
US Senate approves $900 billion stimulus package
The US Senate approved a stimulus package worth nearly $900 billion late on Monday. The vast bill includes but is not limited to nearly $300 billion in small business relief, $166 billion in new cheques and $120 billion to help the unemployed. The bill, which was tied to a wider one providing funding for the federal government, easily passed in both houses of Congress and will now have to be signed by president Donald Trump.
The stimulus package provides clarity for the economy as we head into the new year and steadies the ship until president-elect Joe Biden takes office in January. However, lead Democrat and speaker of the House Nancy Pelosi has already warned that talks about the next round of relief should start sooner rather than later.
European indices broadly flat after heavy sell-off
In Europe, markets were holding largely steady at midday following the sell-off yesterday that was driven by fears over the new strain of coronavirus.
Meanwhile, over the Channel, the FTSE 100 was also slightly higher at midday at 6427.8 from 6423.8.
9 days until Brexit
Hopes of a Brexit deal were raised this morning as the UK and the EU edged closer to an agreement on fisheries but were plunged back into uncertainty after reports that the EU has rejected the UK’s latest offer to break the deadlock.
The UK and the EU were thought to be edging closer toward an agreement after the UK said it wanted to cut the value of fish the EU can catch in UK waters by one-third, compared to a 60% cut proposed last week. Meanwhile, the EU is thought to be standing firm and insisting on no more than a 25% reduction, but that has moved from the bloc’s initial threshold of 18%.
But reports from Bloomberg, citing two unnamed officials, said the EU has rejected that latest offer from the UK. The EU’s chief negotiator Michel Barnier is expected to brief ambassadors from member states at around 1500 GMT at a meeting in Brussels.
UK prime minister Boris Johnson warned yesterday that a no-deal Brexit would be ‘entirely satisfactory’ and the tight timeframe raises questions about whether any deal can be agreed and ratified in time to avoid a no-deal on December 31.
UK out in the cold thanks to new virus strain
In Europe, the focus continues to be the threat of a new strain of coronavirus that is thought to be considerably more transmissible than previous versions. The UK has seen over 40 countries ban UK arrivals and the border with France remains closed, causing carnage for the haulage industry.
European leaders are discussing a co-ordinated approach to the new variant of the virus, while France is looking at how the border could be reopened using new health protocols. It comes as the UK’s chief scientific advisor Patrick Vallance warned it is likely that more areas of the country will need to be put under tougher tier 4 restrictions after Christmas to try and keep on top of the new strain, which health secretary Matt Hancock has described as ‘out of control’.
Meanwhile, the EU is set to secure 12.5 million doses of the Pfizer-BioNTech vaccine before the end of the year after regulators gave it the green light yesterday. EU countries are expected to begin vaccinating their populations as early as Sunday.
CNN also reported Tuesday that Pfizer and Moderna were among those vaccine producers that were testing their vaccines on the new variant of the coronavirus found in the UK to ensure it can still provide immunity. Producers are confident existing vaccines will still prove effective, but it is expected to take weeks to provide any firm insight.
Forex: Pound gains on dollar but loses ground against euro
GBP/USD traded at 1.34190 at midday, down 0.3% from 1.34651 at the end of play on Monday.
EUR/USD was trading slightly lower at 1.22348 from 1.22437.
Meanwhile, Brexit uncertainty saw EUR/GBP move 0.3% higher at 0.91191 at midday from 0.90934 at the close yesterday.
Commodities: Virus fears prevent oil pushing higher
Oil prices climbed to a nine-month high last week on hopes that the introduction of vaccines would allow countries to lift restrictions and get their economies back up and running. However, prices have struggled to move higher since then as fears grow that demand will remain subdued going into 2021 as the new virus strain forces countries to enforce tighter restrictions.
Brent traded at $50.61 at midday, holding steady from $50.87 at the close on Monday, while WTI was at $47.58 from $47.86.
Gold was also broadly flat at $1873 from $1878 at yesterday’s close.
Market-moving events in the economic calendar
Disclaimer: StoneX Financial Ltd (trading as "Forex.com") is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, Forex.com does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.
No opinion given in this material constitutes a recommendation by Forex.com or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although Forex.com is not specifically prevented from dealing before providing this material, Forex.com does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
For further details see our full non-independent research disclaimer and quarterly summary.